Nakamura Toru, Furukawa Yoichi, Nakagawa Hidewaki, Tsunoda Tatsuhiko, Ohigashi Hiroaki, Murata Kohei, Ishikawa Osamu, Ohgaki Kazuhisa, Kashimura Nobuichi, Miyamoto Masaki, Hirano Satoshi, Kondo Satoshi, Katoh Hiroyuki, Nakamura Yusuke, Katagiri Toyomasa
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Oncogene. 2004 Mar 25;23(13):2385-400. doi: 10.1038/sj.onc.1207392.
To characterize molecular mechanism involved in pancreatic carcinogenesis, we analysed gene-expression profiles of 18 pancreatic tumors using a cDNA microarray representing 23,040 genes. As pancreatic ductal adenocarcinomas usually contain a low proportion of cancer cells in the tumor mass, we prepared 95% pure populations of pancreatic cancer cells by means of laser microbeam microdissection, and compared their expression profiles to those of similarly purified, normal pancreatic ductal cells. We identified 260 genes that were commonly upregulated and 346 genes that were downregulated in pancreatic cancer cells. Because of the high degree of purity in the cell populations, a large proportion of genes that we detected as upregulated or downregulated in pancreatic cancers were different from those reported in previous studies. Comparison of clinicopathological parameters with the expression profiles indicated that altered expression of 76 genes was associated with lymph-node metastasis and that of 168 genes with liver metastasis. In addition, expression levels of 30 genes were related to the recurrence of disease. These genome-wide expression profiles should provide useful information for finding candidate genes whose products might serve as specific tumor markers and/or as molecular targets for treatment of patients with pancreatic cancer.
为了阐明胰腺癌发生过程中涉及的分子机制,我们使用一个代表23,040个基因的cDNA微阵列分析了18个胰腺肿瘤的基因表达谱。由于胰腺导管腺癌在肿瘤组织中通常仅含有低比例的癌细胞,我们通过激光微束显微切割技术制备了95%纯度的胰腺癌细胞群体,并将其表达谱与同样经过纯化的正常胰腺导管细胞的表达谱进行了比较。我们鉴定出260个在胰腺癌细胞中共同上调的基因和346个下调的基因。由于细胞群体的高纯度,我们检测到的在胰腺癌中上调或下调的大部分基因与先前研究报道的不同。临床病理参数与表达谱的比较表明,76个基因的表达改变与淋巴结转移相关,168个基因的表达改变与肝转移相关。此外,30个基因的表达水平与疾病复发有关。这些全基因组表达谱应该为寻找候选基因提供有用信息,这些基因的产物可能作为特定的肿瘤标志物和/或作为胰腺癌患者治疗的分子靶点。